{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:41:48Z","timestamp":1780051308983,"version":"3.53.1"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Exploratory Research in Clinical and Social Pharmacy"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.rcsop.2023.100328","type":"journal-article","created":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:25:26Z","timestamp":1693682726000},"page":"100328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["The role of pharmacists in deprescribing benzodiazepines: A scoping review"],"prefix":"10.1016","volume":"12","author":[{"given":"Fatemah Zakariya","family":"Ashkanani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam Pattison","family":"Rathbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Lindsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.rcsop.2023.100328_bb0005","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.maturitas.2016.06.006","article-title":"Deprescribing in older people","volume":"91","author":"Page","year":"2016","journal-title":"Maturitas."},{"issue":"4","key":"10.1016\/j.rcsop.2023.100328_bb0010","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/j.1365-2125.2010.03875.x","article-title":"Quality use of medicines and health outcomes among a cohort of community dwelling older men: an observational study","volume":"71","author":"Beer","year":"2011","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0015","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/bcp.12161","article-title":"Potentially inappropriate prescribing and adverse health outcomes in community dwelling older patients","volume":"77","author":"Cahir","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"11","key":"10.1016\/j.rcsop.2023.100328_bb0020","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1001\/jamainternmed.2014.4103","article-title":"Use of medications of questionable benefit in advanced dementia","volume":"174","author":"Tjia","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0025","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/bcp.12732","article-title":"A systematic review of the emerging definition of \u2018deprescribing\u2019with network analysis: implications for future research and clinical practice","volume":"80","author":"Reeve","year":"2015","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.rcsop.2023.100328_bb0030","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5694\/mja13.00200","article-title":"The benefits and harms of deprescribing","volume":"201","author":"Reeve","year":"2014","journal-title":"Med J Aust"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0035","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2012-001461","article-title":"How are drug regimen changes during hospitalisation handled after discharge: a cohort study","volume":"2","author":"Viktil","year":"2012","journal-title":"BMJ Open"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100328_bb0040","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1111\/j.1532-5415.2008.01916.x","article-title":"Discontinuing medications: a novel approach for revising the prescribing stage of the medication-use process","volume":"56","author":"Bain","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rcsop.2023.100328_bb0045","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1097\/FAD.0b013e328323a63b","article-title":"Adverse reactions to drug withdrawal","volume":"252","author":"Coulson","year":"2008","journal-title":"Adv Drug React Bull"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100328_bb0050","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/bcp.12386","article-title":"Review of deprescribing processes and development of an evidence-based, patient-centred deprescribing process","volume":"78","author":"Reeve","year":"2014","journal-title":"Br J Clin Pharmacol"},{"issue":"suppl 2","key":"10.1016\/j.rcsop.2023.100328_bb0055","first-page":"28","article-title":"Benzodiazepine use, abuse, and dependence","volume":"66","author":"O\u2019Brien","year":"2005","journal-title":"J Clin Psychiatry"},{"issue":"7939","key":"10.1016\/j.rcsop.2023.100328_bb0060","article-title":"Insomnia disorder: management strategies","volume":"305","author":"Paterson","year":"2020","journal-title":"Pharm J"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0065","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2165\/00023210-200418010-00004","article-title":"Cognitive effects of long-term benzodiazepine use","volume":"18","author":"Barker","year":"2004","journal-title":"CNS Drugs"},{"key":"10.1016\/j.rcsop.2023.100328_bb0070","article-title":"Benzodiazepine use and risk of Alzheimer\u2019s disease: case-control study","volume":"349","author":"De Gage","year":"2014","journal-title":"Bmj."},{"issue":"2","key":"10.1016\/j.rcsop.2023.100328_bb0075","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1365-2125.2012.04418.x","article-title":"Benzodiazepine harm: how can it be reduced?","volume":"77","author":"Lader","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.rcsop.2023.100328_bb0080","series-title":"In Adults: Management in Primary, Secondary and Community Care","article-title":"Generalised anxiety disorder and panic disorder (with or without agoraphobia)","author":"Health NIf, Excellence C.","year":"2011"},{"key":"10.1016\/j.rcsop.2023.100328_bb0085","series-title":"British National Formulary (BNF) 70","author":"British Medical Associaton and Royal Pharmaceutical Society","year":"2015"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100328_bb0090","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1001\/archpsyc.1990.01810220015002","article-title":"Long-term therapeutic use of benzodiazepines: I. effects of abrupt discontinuation","volume":"47","author":"Rickels","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100328_bb0095","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1001\/archpsyc.1990.01810220024003","article-title":"Long-term therapeutic use of benzodiazepines: II. Effects of gradual taper","volume":"47","author":"Schweizer","year":"1990","journal-title":"Arch Gen Psychiatry"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100328_bb0100","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/09540260500071863","article-title":"The epidemiology of long-term benzodiazepine use","volume":"17","author":"Neutel","year":"2005","journal-title":"Int Rev Psychiatry"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100328_bb0105","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2105\/AJPH.2016.303061","article-title":"Increasing benzodiazepine prescriptions and overdose mortality in the United States, 1996-2013","volume":"106","author":"Bachhuber","year":"2016","journal-title":"Am J Public Health"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100328_bb0110","doi-asserted-by":"crossref","DOI":"10.3390\/metabo11040204","article-title":"A collaborative deprescribing intervention in a subacute medical outpatient clinic: A pilot randomized controlled trial","volume":"11","author":"Aharaz","year":"2021","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0115","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11096-019-00784-9","article-title":"DEFEAT-polypharmacy: deprescribing anticholinergic and sedative medicines feasibility trial in residential aged care facilities","volume":"41","author":"Ailabouni","year":"2019","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100328_bb0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0252151","article-title":"Pharmacist medication review: an integrated team approach to serve home-based primary care patients","volume":"16","author":"Monz\u00f3n-Kenneke","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.rcsop.2023.100328_bb0125","first-page":"1","article-title":"Feasibility, acceptability and potential effectiveness of an information technology-based, pharmacist-led intervention to prevent an increase in anticholinergic and sedative load among older community-dwelling individuals","volume":"10","author":"van der Meer","year":"2019","journal-title":"Ther Adv Drug Safety"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100328_bb0130","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/bcp.14947","article-title":"Community-based pharmacists\u2019 role in deprescribing: a systematic review","volume":"88","author":"Bu\u017ean\u010di\u0107","year":"2022","journal-title":"Br J Clin Pharmacol"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100328_bb0135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s11096-015-0245-6","article-title":"Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan","volume":"38","author":"Tasaka","year":"2016","journal-title":"Int J Clin Pharm"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100328_bb0140","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/ijpp.12462","article-title":"Community pharmacist-led interventions and their impact on patients\u2019 medication adherence and other health outcomes: a systematic review","volume":"26","author":"Milosavljevic","year":"2018","journal-title":"Int J Pharm Pract"},{"issue":"8","key":"10.1016\/j.rcsop.2023.100328_bb0145","first-page":"927","article-title":"Evaluation of a pharmacist-managed antidiabetic deprescribing program in an integrated health care system","volume":"25","author":"Hui","year":"2019","journal-title":"J Manag Care & Spec Pharm"},{"issue":"5","key":"10.1016\/j.rcsop.2023.100328_bb0150","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1111\/jgs.16388","article-title":"Cost-effectiveness of pharmacist-led deprescribing of NSAIDs in community-dwelling older adults","volume":"68","author":"Sanyal","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.rcsop.2023.100328_bb0155","first-page":"161","article-title":"Anticholinergic discontinuation and cognitive functions in patients with schizophrenia: a pharmacist\u2013physician collaboration in the outpatient department","volume":"7","author":"Sathienluckana","year":"2018","journal-title":"Integr Pharm Res Pract"},{"issue":"7","key":"10.1016\/j.rcsop.2023.100328_bb0160","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019042","article-title":"Reducing the anticholinergic and sedative load in older patients on polypharmacy by pharmacist-led medication review: a randomised controlled trial","volume":"8","author":"van der Meer","year":"2018","journal-title":"BMJ Open"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0165","doi-asserted-by":"crossref","first-page":"47","DOI":"10.4140\/TCP.n.2019.47","article-title":"Implementing a systematic approach to deprescribing proton pump inhibitor therapy in older adults","volume":"34","author":"Coffey","year":"2019","journal-title":"The Senior Care Pharmacist"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100328_bb0170","doi-asserted-by":"crossref","first-page":"698","DOI":"10.4140\/TCP.n.2014.698.","article-title":"Unnecessary lipid-lowering drugs in an outpatient geriatric clinic","volume":"29","author":"Vande Griend","year":"2014","journal-title":"Consult Pharm"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-12-114","article-title":"What is the most appropriate knowledge synthesis method to conduct a review? Protocol for a scoping review","volume":"12","author":"Kastner","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0180","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1177\/1715163515608399","article-title":"A scoping review of research on the prescribing practice of Canadian pharmacists","volume":"148","author":"Faruquee","year":"2015","journal-title":"Canadian Pharm J Revue des Pharmaciens du Canada"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100328_bb0185","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/jgs.15751","article-title":"Deprescribing in the pharmacologic Management of Delirium: a randomized trial in the intensive care unit","volume":"67","author":"Campbell","year":"2019","journal-title":"J Am Geriatr Soc"},{"issue":"3","key":"10.1016\/j.rcsop.2023.100328_bb0190","doi-asserted-by":"crossref","DOI":"10.1136\/bmjoq-2018-000539","article-title":"Deprescribing benzodiazepines among hospitalised older adults: quality improvement initiative","volume":"8","author":"Carr","year":"2019","journal-title":"BMJ Open Qual"},{"issue":"10","key":"10.1016\/j.rcsop.2023.100328_bb0195","doi-asserted-by":"crossref","first-page":"678","DOI":"10.4140\/TCP.n.2019.678","article-title":"Targeted medication Deprescribing in the elderly: results of a pharmacist-driven procedure in a transitional care unit","volume":"34","author":"Feldman","year":"2019","journal-title":"Sr Care Pharm"},{"issue":"2","key":"10.1016\/j.rcsop.2023.100328_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9020348","article-title":"A collaborative medication review including deprescribing for older patients in an emergency department: A longitudinal feasibility study","volume":"9","author":"Houlind","year":"2020","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0205","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1071\/AH14219","article-title":"Effects of a pilot multidisciplinary clinic for frequent attending elderly patients on deprescribing","volume":"40","author":"Mudge","year":"2016","journal-title":"Australian Health Rev A Publicat Australian Hosp Associat"},{"key":"10.1016\/j.rcsop.2023.100328_bb0210","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ajp.2019.07.041","article-title":"Deprescribing of benzodiazepines and Z-drugs amongst the psychiatric patients of a tertiary care hospital","volume":"44","author":"Shilpa","year":"2019","journal-title":"Asian J Psychiatr"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0215","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/jgs.15300","article-title":"EMPOWERing hospitalized older adults to deprescribe sedative hypnotics: a pilot study","volume":"66","author":"Wilson","year":"2018","journal-title":"J Am Geriatr Soc"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0220","first-page":"71","article-title":"The development and evaluation of an oncological palliative care deprescribing guideline: the \u2018OncPal deprescribing guideline\u2019","volume":"23","author":"Lindsay","year":"2015","journal-title":"Support Care Cancer"},{"issue":"18","key":"10.1016\/j.rcsop.2023.100328_bb0225","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1001\/jama.2018.16131","article-title":"Effect of a pharmacist-led educational intervention on inappropriate medication prescriptions in older adults: the D-PRESCRIBE randomized clinical trial","volume":"320","author":"Martin","year":"2018","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0230","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamainternmed.2014.949","article-title":"Reduction of inappropriate benzodiazepine prescriptions among older adults through direct patient education: the EMPOWER cluster randomized trial","volume":"174","author":"Tannenbaum","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0235","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/gerona\/glaa180","article-title":"Economic evaluation of sedative deprescribing in older adults by community pharmacists","volume":"76","author":"Turner","year":"2021","journal-title":"J Gerontol"},{"issue":"4","key":"10.1016\/j.rcsop.2023.100328_bb0240","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1177\/17151635211014918","article-title":"Pharmacist-led sedative-hypnotic deprescribing in team-based primary care practice","volume":"154","author":"Lui","year":"2021","journal-title":"Canadian Pharmac J"},{"issue":"9","key":"10.1016\/j.rcsop.2023.100328_bb0245","doi-asserted-by":"crossref","first-page":"398","DOI":"10.5694\/mja17.00857","article-title":"RedUSe: reducing antipsychotic and benzodiazepine prescribing in residential aged care facilities","volume":"208","author":"Westbury","year":"2018","journal-title":"Med J Aust"},{"issue":"1","key":"10.1016\/j.rcsop.2023.100328_bb0250","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.sapharm.2017.01.003","article-title":"Self-efficacy for deprescribing: a survey for health care professionals using evidence-based deprescribing guidelines","volume":"14","author":"Farrell","year":"2018","journal-title":"Res Soc Administrat Pharm RSAP"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0255","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4140\/TCP.n.2018.331","article-title":"Deprescribing in newly admitted psychogeriatric nursing facility patients","volume":"33","author":"Blenke","year":"2018","journal-title":"Consult Pharm"},{"issue":"12","key":"10.1016\/j.rcsop.2023.100328_bb0260","first-page":"4105","article-title":"Pharmacist-led medication assessment and deprescribing intervention for older adults with cancer and polypharmacy: a pilot study","volume":"26","author":"Whitman","year":"2018","journal-title":"Support Care Cancer"},{"issue":"6","key":"10.1016\/j.rcsop.2023.100328_bb0265","doi-asserted-by":"crossref","first-page":"331","DOI":"10.4140\/TCP.n.2018.331","article-title":"Deprescribing in newly admitted psychogeriatric nursing facility patients","volume":"33","author":"Blenke","year":"2018","journal-title":"Consult Pharm"},{"issue":"Supplement 2","key":"10.1016\/j.rcsop.2023.100328_bb0270","first-page":"S114","article-title":"Deprescribing benzodiazepines in hospitalized seniors using a patient-education intervention","volume":"66","author":"Carr","year":"2018","journal-title":"J Am Geriatr Soc"}],"container-title":["Exploratory Research in Clinical and Social Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276623001099?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2667276623001099?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T08:30:02Z","timestamp":1757406602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2667276623001099"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":54,"alternative-id":["S2667276623001099"],"URL":"https:\/\/doi.org\/10.1016\/j.rcsop.2023.100328","relation":{},"ISSN":["2667-2766"],"issn-type":[{"value":"2667-2766","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of pharmacists in deprescribing benzodiazepines: A scoping review","name":"articletitle","label":"Article Title"},{"value":"Exploratory Research in Clinical and Social Pharmacy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rcsop.2023.100328","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100328"}}